ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, X.
Right arrow Articles by Kiechle, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, X.
Right arrow Articles by Kiechle, F.
Annals of Clinical & Laboratory Science 31:187-198 (2001)
© 2001 Association of Clinical Scientists

Hoechst 33342-Induced Apoptosis is Associated with Decreased Immunoreactive Topoisomerase I and Topoisomerase I-DNA Complex Formation

Xinbo Zhang and Frederick Kiechle
Department of Clinical Pathology, William Beaumont Hospital, Royal Oak, Michigan

Address correspondence to Frederick Kiechle, M.D., Ph.D., Department of Clinical Pathology, William Beaumont Hospital, 3601 West 13 Mile Road, Royal Oak, Michigan 48073-6769, USA; tel 248 551 8020; fax 248 551 3694; e-mail fkiechle{at}beaumont.edu.

Hoechst 33342, but not Hoechst 33258, induces apoptosis and inhibits topoisomerase 1 activity in vivo. Topoisomerase I relaxes superhelical DNA through a single strand breakage/rejoining reaction in which the active site tyrosine links covalently to a 3' phosphate at the break site, forming a transient intermediate called a cleavable complex. The fate of cellular topoisomerase 1 in Hoechst 33342-induced apoptosis is unknown. We analyzed the binding capacity of topoisomerase 1 to 32P-labeled plasmid pCI DNA, the immunoreactive topoisomerase 1 concentration and topoisomerase 1 activity in BC3H-1 myocytes and HL-60 cells treated with Hoechst 33342 and Hoechst 33258 by using covalent transfer of 32P radioactivity from plasmid DNA to topoisomerase 1, Western blotting and topoisomerase 1-mediated plasmid relaxation assay, respectively. Hoechst 33342, but not Hoechst 33258, induced topoisomerase 1 dysfunction in both BC3H-1 myocytes and HL-60 cells measured by (1) a decrease in the topoisomerase 1 to DNA binding capacity or cleavable complex formation; (2) a decrease in intracellular concentration of immunoreactive topoisomerase 1; and (3) an inhibition of nuclear endogenous topoisomerase 1 activity. These results suggest that destruction of immunoreactive topoisomerase 1 and topoisomerase 1-DNA complexes or cleavable complexes results in inhibition of topoisomerase 1 activity, a key step in the Hoechst 33342-induced apoptotic process.

Keywords: Apoptosis, Hoechst 33342, Hoechst 33258, topoisomerase I, topoisomerase I-DNA complex

Abbreviations: TOP1, topoisomerase I; TOP2, topoisomerase II; H342, Hoechst 33342; H258, Hoechst 33258; FBS, fetal bovine serum; MEME, minimum essential medium Eagle; BCA, bicinchoninic acid; SDS, sodium dodecyl sulfate




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
G. A. Abel, G. M. Wochnik, J. Ruegg, A. Rouyer, F. Holsboer, and T. Rein
Activity of the GR in G2 and Mitosis
Mol. Endocrinol., June 1, 2002; 16(6): 1352 - 1366.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Association of Clinical Scientists.